Cited by 5,141Research on Leishmaniasis StudiesLeprosy Research and TreatmentBrucella: diagnosis, epidemiology, treatment

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Open access

Alvar, Jorge, Vélez, Iván D., Bern, Caryn, Herrero, Mercé, Desjeux, Philippe, Cano, Jorge, Jannin, Jean, Boer, Margriet den, the WHO Leishmaniasis Control Team·2012·PLoS ONE

DOI 10.1371/journal.pone.0035671PMC PMC3365071

Open this paper in CoChat — free account Open PDF

Abstract

As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0035671

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
Background
World Development Report 1993
Bank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
Background
Health metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
Background
Leishmaniasis and poverty
Alvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
Background
Leishmaniasis
Desjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
Background
Control Of The Leishmaniases
Library, W. (2010) · Cited by 584

Flagged first, then by citations

Show all 51 references

Research works printed but not linked: 1

AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931

Sorted by citations

Items 601–700 of 1,004

A Newly Emerged Cutaneous Leishmaniasis Focus in Northern Israel and Two New Reservoir Hosts of Leishmania major
Faiman, R., Abbasi, I., Jaffe, C. L., Motro, Y., Nasereddin, A., Schnur, L. F., Torem, M., Pratlong, F., Dedet, J.-P., & Warburg, A. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002058 · Cited by 51
First record of Leishmania braziliensis presence detected in bats, Mato Grosso do Sul, southwest Brazil
Shapiro, J. T., Lima, M. S. D. C., Dorval, M. E. C., França, A. D. O., Matos, M. D. F. C., & Bordignon, M. O. (2013) · Acta Tropica · doi:10.1016/j.actatropica.2013.07.004 · Cited by 51
Endemic Transmission of Visceral Leishmaniasis in Bhutan
Yangzom, T., Cruz, I., Bern, C., Argaw, D., den Boer, M., Vélez, I. D., Bhattacharya, S. K., Molina, R., & Alvar, J. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0211 · Cited by 51
Could Phlebotomus mascittii play a role as a natural vector for Leishmania infantum? New data
Obwaller, A. G., Karakuş, M., Poeppl, W., Töz, S. O., Özbel, Y., Aspöck, H., & Walochnik, J. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1750-8 · Cited by 50
Canine visceral leishmaniasis in the metropolitan area of São Paulo: Pintomyia fischeri as potential vector of Leishmania infantum
Galvis‐Ovallos, F., da Silva, M. D., Bispo, G. B. D. S., de Oliveira, A. G., Neto, J. R. G., Malafronte, R. D. S., & Galati, E. A. B. (2017) · Parasite · doi:10.1051/parasite/2017002 · Cited by 51
Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP
Simon, S., Nacher, M., Carme, B., Basurko, C., Roger, A., Adenis, A. A., Ginouvès, M., Demar, M., & Couppié, P. (2017) · Tropical Medicine and Health · doi:10.1186/s41182-017-0045-x · Cited by 51
L-arginine availability and arginase activity: Characterization of amino acid permease 3 in Leishmania amazonensis
Aoki, J. I., Muxel, S. M., Zampieri, R. A., Acuña, S. M., Fernandes, J. C. R., Vanderlinde, R. H., Sales, M. C. O. D. P., & Floeter‐Winter, L. M. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006025 · Cited by 51
Thein vitroantileishmanial activity of essential oil fromAloysia gratissimaand guaiol, its major sesquiterpene againstLeishmania amazonensis
Garcia, M. C. F., Soares, D. C., Santana, R. C., Saraiva, E. M., Siani, A. C., Ramos, M. F. D. S., Danelli, M. D. G. M., Souto-Padrón, T. C. B. S., & Pinto-da-Silva, L. H. (2018) · Parasitology · doi:10.1017/s0031182017002335 · Cited by 54
Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation
Palić, S., Bhairosing, P. A., Beijnen, J. H., & Dorlo, T. P. C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02507-18 · Cited by 51
Ecological niche modelling for predicting the risk of cutaneous leishmaniasis in the Neotropical moist forest biome
Chavy, A., Nava, A. F. D., Luz, S. L. B., Ramírez, J. D., Herrera, G., dos Santos, T. V., Ginouvès, M., Demar, M., Prévot, G., Guégan, J., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007629 · Cited by 54
A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis
Kumar, A., Pandey, S. C., & Samant, M. (2020) · Parasite Immunology · doi:10.1111/pim.12727 · Cited by 51
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection
Lage, D. P., Ribeiro, P. A. F., Dias, D. S., Mendonça, D. V. C., Ramos, F. F., Carvalho, L. M., de Oliveira, D., Steiner, B. T., Martins, V. T., Perin, L., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-00224-0 · Cited by 51
Characterization of a new Leishmania major strain for use in a controlled human infection model
Ashwin, H. M., Sádlová, J., Vojtková, B., Bečvář, T., Lypaczewski, P., Schwartz, E., Greensted, E., Bocxlaer, K. V., Pasin, M., Lipinski, K. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20569-3 · Cited by 51
Identification of asymptomatic Leishmania infections: a scoping review
Ibarra‐Meneses, A. V., Corbeil, A., Wagner, V., Onwuchekwa, C., & Fernandez‐Prada, C. (2022) · Parasites & Vectors · doi:10.1186/s13071-021-05129-y · Cited by 51
(−)-α-Bisabolol, a Promising Oral Compound for the Treatment of Visceral Leishmaniasis
Corpas‐López, V., Morillas‐Márquez, F., Moll, M. C. N., Merino‐Espinosa, G., Díaz‐Sáez, V., & Martín‐Sánchez, J. (2015) · Journal of Natural Products · doi:10.1021/np5008697 · Cited by 51
Pathways of iron acquisition and utilization in Leishmania
Flannery, A. R., Renberg, R. L., & Andrews, N. W. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.07.018 · Cited by 50
Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review
Piccica, M., Lagi, F., Bartoloni, A., & Zammarchi, L. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab065 · Cited by 50
Lipid and fatty acid metabolism in trypanosomatids
de Aquino, G. P., Gomes, M. A. M., Salinas, R. K., & Laranjeira‐Silva, M. F. (2021) · Microbial Cell · doi:10.15698/mic2021.11.764 · Cited by 50
In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani
Saha, S., Vashishtha, S., Kundu, B., & Ghosh, M. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04816-6 · Cited by 50
Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model
Katebi, A., Gholami, E., Taheri, T., Zahedifard, F., Habibzadeh, S., Taslimi, Y., Shokri, F., Papadopoulou, B., Kamhawi, S., Valenzuela, J. G., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.08.001 · Cited by 50
The Dialogue of the Host-Parasite Relationship:Leishmaniaspp. andTrypanosoma cruziInfection
Morais, C. G., Lima, A. K. C., Terra, R., dos Santos, R. F., Da-Silva, S. A. G., & Dutra, P. M. L. (2015) · BioMed Research International · doi:10.1155/2015/324915 · Cited by 50
Diverse modes of binding in structures ofLeishmania majorN-myristoyltransferase with selective inhibitors
Brannigan, J. A., Roberts, S. M., Bell, A., Hutton, J. A., Hodgkinson, M. R., Tate, E. W., Leatherbarrow, R. J., Smith, D. F., & Wilkinson, A. J. (2014) · IUCrJ · doi:10.1107/s2052252514013001 · Cited by 50
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
Chamakh-Ayari, R., Bras‐Gonçalves, R., Bahi-Jaber, N., Petitdidier, E., Markikou-Ouni, W., Aoun, K., Moreno, J., Carrillo, E., Salotra, P., Kaushal, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092708 · Cited by 50
Synthesis and activity of novel tetrazole compounds and their pyrazole-4-carbonitrile precursors against Leishmania spp
Faria, J. V., dos Santos, M. S., Bernardino, A. M. R., Becker, K. M., Machado, G. M. C., Rodrigues, R. F., Canto‐Cavalheiro, M. M., & Leon, L. L. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.062 · Cited by 50
In Vitro Antileishmanial Activity of Essential Oil of Vanillosmopsis arborea (Asteraceae) Baker
Colares, A. V., Almeida-Souza, F., Taniwaki, N. N., de Souza, C. D. S. F., da Costa, J. G. M., Calabrese, K. D. S., & Abreu‐Silva, A. L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/727042 · Cited by 50
Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines
Manda, S., Khan, S. I., Jain, S. K., Mohammed, S., Tekwani, B. L., Khan, I. A., Vishwakarma, R. A., & Bharate, S. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.030 · Cited by 50
Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models
Rutte, E. A. L., Coffeng, L. E., Bontje, D. M., Hasker, E. C., Ruiz-Postigo, J. A., Argaw, D., Boelaert, M., & de Vlas, S. J. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1292-0 · Cited by 48
Optimization of loop-mediated isothermal amplification (LAMP) assays for the detection of Leishmania DNA in human blood samples
Abbasi, I., Kirstein, O. D., Hailu, A., & Warburg, A. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.06.009 · Cited by 50
Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis
Ghosh, P., Bhaskar, K. R. H., Hossain, F., Khan, M. A. A., Vallur, A. C., Duthie, M. S., Hamano, S., Salam, M. A., Huda, M. M., Khan, M. G. M., et al. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1667-2 · Cited by 50
Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression
Medina-Colorado, A. A., Osorio, E. Y., Saldarriaga, Ó. A., Travi, B. L., Kong, F., Spratt, H. M., Soong, L., & Melby, P. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169496 · Cited by 48
Visceral leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?
de Sousa-Gomes, M. L., Romero, G. A. S., & Werneck, G. L. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005772 · Cited by 50
The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis
Conceição‐Silva, F., Leite-Silva, J., & Morgado, F. N. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01308 · Cited by 50
Antileishmanial Activity of Amphotericin B-loaded-PLGA Nanoparticles: An Overview
Palma, E., Pasqua, A., Gagliardi, A., Britti, D., Fresta, M., & Cosco, D. (2018) · Materials · doi:10.3390/ma11071167 · Cited by 50
Correlates of GLA family adjuvants’ activities
Reed, S. G., Carter, D., Casper, C., Duthie, M. S., & Fox, C. B. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.10.004 · Cited by 50
Bio-guided profiling and HPLC-DAD finger printing of Atriplex lasiantha Boiss
Zohra, T., Ovais, M., Khalil, A. T., Qasim, M., Ayaz, M., Shinwari, Z. K., Ahmad, S., & Zahoor, M. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2416-1 · Cited by 50
Leishmania flagellum attachment zone is critical for flagellar pocket shape, development in the sand fly, and pathogenicity in the host
Sunter, J. D., Yanase, R., Wang, Z., Catta‐Preta, C. M. C., Moreira-Leite, F. F., Myšková, J., Pružinová, K., Volf, P., Mottram, J. C., & Keith Gull, B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812462116 · Cited by 50
Antileishmanial activity of extracts from Libidibia ferrea: development of in vitro and in vivo tests
Wyrepkowski, C. D. C., Jensen, B. B., Grafov, A., dos Santos, P. A., Barros, A. M. C., Soares, F. V., Barcellos, J. F. M., da SILVA, A. F., Grafov, A., & Franco, A. M. R. (2017) · Acta Amazonica · doi:10.1590/1809-4392201700871 · Cited by 49
Potential of the natural products against leishmaniasis in Old World - a review of in-vitro studies
Cortes, S., de Sousa, C. B., Morais, T. R., Lago, J. H. G., & Campino, L. (2020) · Pathogens and Global Health · doi:10.1080/20477724.2020.1754655 · Cited by 49
Cheminformatics-based discovery of new organoselenium compounds with potential for the treatment of cutaneous and visceral leishmaniasis
Ugbe, F. A., Shallangwa, G. A., Uzairu, A., Abdulkadir, I., Edache, E. I., Al‐Megrin, W. A. I., Al‐Shouli, S. T., Wang, Y., & Abdalla, M. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2279269 · Cited by 51
“There are almost 0.2-0.4 million VL cases annually with approximately triple that number for the cutaneous form (Alvar et al., 2012).”
Influential
A review on quinolines: New green synthetic methods and bioactive potential
Ferreira, L. M., Garcı́a, P. G., García, P. A., & Castro, M. A. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107097 · Cited by 52
Facile and expedient access to bis-coumarin–iminothiazole hybrids by molecular hybridization approach: synthesis, molecular modelling and assessment of alkaline phosphatase inhibition, anticancer and antileishmanial potential
Ibrar, A., Zaib, S., Khan, I. A., Jabeen, F., Iqbal, J., & Saeed, A. (2015) · RSC Advances · doi:10.1039/c5ra14900b · Cited by 49
Identification of Metal Dithiocarbamates as a Novel Class of Antileishmanial Agents
Pal, D. S., Mondal, D. K., & Datta, R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05146-14 · Cited by 47
Cutaneous and post kala-azar dermal leishmaniasis caused byLeishmania infantumin endemic areas of visceral leishmaniasis, northwestern Iran 2002–2011: a case series
Badirzadeh, A., Mohebali, M., Ghasemian, M., Amini, H., Zarei, Z., Akhoundi, B., Hajjaran, H., Emdadi, D., Molaei, S., Kousha, A., et al. (2013) · Pathogens and Global Health · doi:10.1179/2047773213y.0000000097 · Cited by 49
Antileishmanial activity of a mixture of Tridax procumbens and Allium sativum in mice
Gamboa‐León, R., Vera‐Ku, M., Peraza-Sánchez, S. R., Ku-Chulim, C., Horta-Baas, A., & Rosado-Vallado, M. E. (2014) · Parasite · doi:10.1051/parasite/2014016 · Cited by 49
Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010.
Picado, A., Dash, A. P., Bhattacharya, S., & Boelaert, M. (2012) · PubMed Central · Cited by 48
In vitro Susceptibility of Leishmania donovani to Miltefosine in Indian Visceral Leishmaniasis
Prajapati, V. K., Sharma, S., Rai, M., Ostyn, B., Salotra, P., Vanaerschot, M., Dujardin, J., & Sundar, S. (2013) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0096 · Cited by 49
Experimental Resistance to Drug Combinations in Leishmania donovani: Metabolic and Phenotypic Adaptations
Berg, M., García‐Hernández, R., Cuypers, B., Vanaerschot, M., Manzano, J. I., Poveda, J. A., Ferragut, J. A., Castanys, S., Dujardin, J., & Gamarro, F. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04231-14 · Cited by 53
The membrane as the gatekeeper of infection: Cholesterol in host–pathogen interaction
Kumar, G. A., Jafurulla, M., & Chattopadhyay, A. (2016) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2016.02.007 · Cited by 49
Drug permeation and barrier damage in Leishmania -infected mouse skin
Bocxlaer, K. V., Yardley, V., Murdan, S., & Croft, S. L. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw012 · Cited by 49
High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania
Pandey, R. K., Verma, P., Sharma, D., Bhatt, T. K., Sundar, S., & Prajapati, V. K. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.010 · Cited by 49
Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials
López‐Carvajal, L., Cardona‐Arias, J. A., Zapata-Cardona, M. I., Sánchez-Giraldo, V., & Vélez, I. D. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1663-3 · Cited by 49
Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine
Agallou, M., Margaroni, M., Athanasiou, E., Toubanaki, D. K., Kontonikola, K., Karidi, K., Kammona, O., Kiparissides, C. A., & Karagouni, E. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005311 · Cited by 49
Redundant and regulatory roles for Toll-like receptors inLeishmaniainfection
Chauhan, P. S., Shukla, D., Chattopadhyay, D., & Saha, B. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13014 · Cited by 50
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis
Dias, D. S., Ribeiro, P. A. F., Martins, V. T., Lage, D. P., Ramos, F. F., Dias, A. L. T., Rodrigues, M. R., Portela, Á. S. B., Costa, L. E., Caligiorne, R. B., et al. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.11.001 · Cited by 49
Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study
Chakravarty, J., Hasker, E. C., Kansal, S., Singh, O. P., Malaviya, P., Singh, A. K., Chourasia, A., Singh, T. N., Sudarshan, M., Singh, A. P., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007216 · Cited by 49
An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of Trypanosoma cruzi That Depicts the Multifunctionality and Dysfunctionality of T Cells
Mateus, J., Guerrero-Alonso, P., Lasso, P., Cuervo, C., González, J. M., Puerta, C. J., & Cuéllar, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00918 · Cited by 49
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital
Garrido-Jareño, M., Sahuquillo‐Torralba, A., Chouman-Arcas, R., Hernández, I. C., Molina-Moreno, J. M., Llavador‐Ros, M., Gómez‐Ruiz, M. D., López-Hontangas, J. L., Estrada, R. B., Salavert, M., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-3901-1 · Cited by 49
Anti Leishmania activity of Lucilia sericata and Calliphora vicina maggots in laboratory models
Sanei-Dehkordi, A., Khamesipour, A., Akbarzadeh, K., Akhavan, A. A., Mohammadi, A. M., Mohammadi, Y., Rassi, Y., Oshaghi, M. A., Alebrahim, Z., Eskandari, S. E., et al. (2016) · Experimental Parasitology · doi:10.1016/j.exppara.2016.08.007 · Cited by 48
Treatment and long-term follow-up of a cat with leishmaniosis
Brianti, E., Celi, N., Napoli, E., Abbate, J. M., Arfuso, F., Gaglio, G., Iatta, R., Giannetto, S., GRAMICCIA, M., & Otranto, D. (2019) · Parasites & Vectors · doi:10.1186/s13071-019-3388-9 · Cited by 48
A Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantum
Rojo, D., Canuto, G. A. B., Castilho-Martins, E. A., Tavares, M. F. M., Barbas, C., López‐Gonzálvez, Á., & Rivas, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130675 · Cited by 48
Fitness of Leishmania donovani Parasites Resistant to Drug Combinations
García‐Hernández, R., Gómez‐Pérez, V., Castanys, S., & Gamarro, F. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003704 · Cited by 48
In vitro and in vivo evaluation of anti-leishmanial and immunomodulatory activity of Neem leaf extract in Leishmania donovani infection
Alti, D., Chandrasekaran, S., Veronica, J., Sundar, S., & Maurya, R. (2015) · Experimental Parasitology · doi:10.1016/j.exppara.2015.02.011 · Cited by 48
Leishmania Promastigotes Induce Cytokine Secretion in Macrophages through the Degradation of Synaptotagmin XI
Arango Duque, G., Fukuda, M., Turco, S. J., Stäger, S., & Descoteaux, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303043 · Cited by 48
Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis
Duarte, M. C., Tavares, G. S. V., Valadares, D. G., Lage, D. P., Ribeiro, T. G., Lage, L. M. D. R., Rodrigues, M. R., Faraco, A. A. G., Soto, M., da Silva, E. S., et al. (2016) · Experimental Parasitology · doi:10.1016/j.exppara.2016.03.026 · Cited by 48
Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model
Bocxlaer, K. V., Yardley, V., Murdan, S., & Croft, S. L. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12548 · Cited by 48
Plumbagin, a plant-derived naphthoquinone metabolite induces mitochondria mediated apoptosis-like cell death in Leishmania donovani: an ultrastructural and physiological study
Awasthi, B. P., Kathuria, M., Pant, G., Kumari, N., & Mitra, K. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1259-9 · Cited by 48
Poloxamer 407 (Pluronic® F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis
Mendonça, D. V. C., Lage, L. M. D. R., Lage, D. P., Chávez‐Fumagalli, M. Á., Ludolf, F., Roatt, B. M., Menezes‐Souza, D., Faraco, A. A. G., Castilho, R. O., Tavares, C. A. P., et al. (2016) · Experimental Parasitology · doi:10.1016/j.exppara.2016.07.005 · Cited by 48
Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery
Mendonça, S. C. F. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1777-x · Cited by 48
Climate and environmental factors affecting the incidence of cutaneous leishmaniasis in Isfahan, Iran
Ramezankhani, R., Sajjadi, N., Esmaeilzadeh, R. N., Jozi, S. A., & Shirzadi, M. R. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-1340-8 · Cited by 48
Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis
Wijnant, G.-J., Bocxlaer, K. V., Yardley, V., Harris, A., Alavijeh, M. S., Silva-Pedrosa, R., Antunes, S., Maurício, I. L., Murdan, S., & Croft, S. L. (2018) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2018.04.001 · Cited by 48
Diethyldithiocarbamate loaded in beeswax-copaiba oil nanoparticles obtained by solventless double emulsion technique promote promastigote death in vitro
Mazur, K. L., Feuser, P. E., Valério, A., Cordeiro, A. P., de Oliveira, C. I., Assolini, J. P., Pavanelli, W. R., Sayer, C., & de Araújo, P. H. H. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.12.048 · Cited by 48
Infection of Human Neutrophils With Leishmania infantum or Leishmania major Strains Triggers Activation and Differential Cytokines Release
Oualha, R., Barhoumi, M., Marzouki, S., Harigua‐Souiai, E., Ahmed, M. B., & Guizani, I. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00153 · Cited by 48
Natural Occurrence in Venomous Arthropods of Antimicrobial Peptides Active against Protozoan Parasites
Júnior, E. F. S., Menezes, L. F. S., de Araújo, I. F. S., & Schwartz, E. F. (2019) · Toxins · doi:10.3390/toxins11100563 · Cited by 46
Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani
Potvin, J.-É., Leprohon, P., Queffeulou, M., Sundar, S., & Ouellette, M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1236 · Cited by 47
Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection
de Sá, K. S. G., Amaral, L. A., Rodrigues, T. S., Ishimoto, A. Y., Andrade, W. A., de Almeida, L., Freitas-Castro, F., Batah, S. S., Oliveira, S. C., Pastorello, M. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36626-6 · Cited by 49
Correlation between presence of Leishmania RNA virus 1 and clinical characteristics of nasal mucosal leishmaniosis
Ito, M. M., Cantanhêde, L. M., Katsuragawa, T. H., Júnior, C. F. D. S., Camargo, L. M. A., Ferreira, R. D. G. M., & Vilallobos-Salcedo, J. M. (2015) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2015.07.014 · Cited by 47
Cutaneous leishmaniasis: knowledge, attitude and practices of the inhabitants of the Kani forest tribal settlements of Tiruvananthapuram district, Kerala, India
Nandha, B., Srinivasan, R., & Jambulingam, P. (2014) · Health Education Research · doi:10.1093/her/cyu064 · Cited by 47
Leishmania infantum in wild rodents: reservoirs or just irrelevant incidental hosts?
Navea-Pérez, H. M., Díaz‐Sáez, V., Corpas‐López, V., Merino‐Espinosa, G., Morillas‐Márquez, F., & Martín‐Sánchez, J. (2015) · Parasitology Research · doi:10.1007/s00436-015-4434-y · Cited by 54
Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
Sudarshan, M., Singh, T. N., Singh, A. K., Chourasia, A., Singh, B., Wilson, M. E., Chakravarty, J., & Sundar, S. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003366 · Cited by 47
Single-Dose Indigenous Liposomal Amphotericin B in the Treatment of Indian Visceral Leishmaniasis: A Phase 2 Study
Sundar, S., Singh, A. K., Rai, M., & Chakravarty, J. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0259 · Cited by 47
Severity of Old World Cutaneous Leishmaniasis Is Influenced by Previous Exposure to Sandfly Bites in Saudi Arabia
Mondragón-Shem, K., Al-Salem, W. S., Kelly‐Hope, L. A., Abdeladhim, M., Al-Zahrani, M. H., Valenzuela, J. G., & Acosta-Serrano, Á. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003449 · Cited by 47
Leishmanization revisited: Immunization with a naturally attenuated cutaneous Leishmania donovani isolate from Sri Lanka protects against visceral leishmaniasis
McCall, L., Zhang, W., Ranasinghe, S., & Matlashewski, G. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.065 · Cited by 47
Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study
Perry, M. R., Prajapati, V. K., Menten, J., Raab, A., Feldmann, J., Chakraborti, D., Sundar, S., Fairlamb, A. H., Boelaert, M., & Picado, A. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003518 · Cited by 47
Quantification of the natural history of visceral leishmaniasis and consequences for control
Chapman, L. A. C., Dyson, L., Courtenay, O., Chowdhury, R., Bern, C., Medley, G. F., & Hollingsworth, T. D. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-1136-3 · Cited by 47
In Vitro Study on Cytotoxic Effects of ZnO Nanoparticles on Promastigote and Amastigote Forms of Leishmania major (MRHO/IR/75/ER).
Delavari, M., Dalimi, A., Ghaffarifar, F., & Sadraei, J. (2014) · Europe PMC (PubMed Central) · Cited by 47
Post-Genomics and Vaccine Improvement for Leishmania
Seyed, N., Taheri, T., & Rafati, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00467 · Cited by 47
A recombinant chimeric protein composed of human and mice‐specific CD 4+ and CD 8+ T‐cell epitopes protects against visceral leishmaniasis
Martins, V. T., Duarte, M. C., Lage, D. P., Costa, L. E., Carvalho, A. M. R. S., Mendes, T. A. D. O., Roatt, B. M., Menezes‐Souza, D., Soto, M., & Coelho, E. A. F. (2016) · Parasite Immunology · doi:10.1111/pim.12359 · Cited by 47
Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India
Ejazi, S. A., Bhattacharya, P., Bakhteyar, M. A. K., Mumtaz, A., Pandey, K., Das, V. N. R., Das, P. K., Rahaman, M., Goswami, R. P., & Ali, N. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005035 · Cited by 47
Leishmaniases in Ecuador: Comprehensive review and current status
Hashiguchi, Y., Velez, L. N., Villegas, N. V., Mimori, T., Gómez, E. A., & Kato, H. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.11.039 · Cited by 47
Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c mice
Amit, A., Vijayamahantesh, V., Dikhit, M. R., Singh, A. K., Kumar, V., Suman, S. S., Singh, A., Kumar, A., Thakur, A. K., Das, V. N. R., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2016.12.022 · Cited by 47
A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden
Roatt, B. M., Aguiar‐Soares, R. D. D. O., Reis, L. E. S., Cardoso, J. M. D. O., Mathias, F. A. S., de Brito, R. C. F., da Silva, S. M., Gontijo, N. F., Ferreira, S. D. A., Valenzuela, J. G., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00217 · Cited by 47
Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India
Garapati, P., Pal, B., Siddiqui, N. A., Bimal, S., Das, P. K., Murti, K., & Pandey, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203407 · Cited by 47
Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB/c mice
Kavian, Z., Alavizadeh, S. H., Golmohammadzadeh, S., Badiee, A., Khamesipour, A., & Jaafari, M. R. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.05.018 · Cited by 47
Comorbid infections induce progression of visceral leishmaniasis
Toepp, A. J., Monteiro, G. R., Coutinho, J. F. V., Lima, A. L., Larson, M., Wilson, G., Grinnage‐Pulley, T., Bennett, C., Mahachi, K. G., Anderson, B., et al. (2019) · Parasites & Vectors · doi:10.1186/s13071-019-3312-3 · Cited by 47
Prevalence and environmental determinants of cutaneous leishmaniasis in rural communities in Tigray, northern Ethiopia
Yohannes, M., Abebe, Z., & Boelee, E. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007722 · Cited by 47
Nano-co-delivery of lipophosphoglycan with soluble and autoclaved leishmania antigens into PLGA nanoparticles: Evaluation of in vitro and in vivo immunostimulatory effects against visceral leishmaniasis
Tosyalı, Ö. A., Allahverdiyev, A., Bağırova, M., Abamor, E. Ş., Aydoğdu, M. O., Dinparvar, S., Acar, T., Mustafaeva, Z., & Derman, S. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111684 · Cited by 48
Development of an Amplicon-Based Next-Generation Sequencing Protocol to Identify Leishmania Species and Other Trypanosomatids in Leishmaniasis Endemic Areas
Patiño, L. H., Castillo-Castañeda, A. C., Muñoz, M., Jaimes, J. E., Luna-Niño, N., Hernández, C., Ayala, M. S., Fuya, P., Méndez, C., Hernández‐Pereira, C. E., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00652-21 · Cited by 46
Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines
Trivedi, P. D., Byrne, B. J., & Corti, M. (2023) · Viruses · doi:10.3390/v15122378 · Cited by 53
Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum
Lage, P. S., Chávez‐Fumagalli, M. Á., Mesquita, J. T., Mata, L. M., Fernandes, S. O. A., Cardoso, V. N., Soto, M., Tavares, C. A. P., Leite, J. P. V., Tempone, A. G., et al. (2015) · Parasitology Research · doi:10.1007/s00436-015-4708-4 · Cited by 46
Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania
de Mendonça, S. C. F., Cysne‐Finkelstein, L., & Matos, D. C. D. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00524 · Cited by 46

Authors: Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
Affiliations: World Health Organization (CH)
Universidad de Antioquia (CO)
Centers for Disease Control and Prevention (US)
Instituto de Salud Carlos III (ES)
Corresponding author: Alvar, Jorge
ORCID: Alvar, Jorge
Vélez, Iván D.
Bern, Caryn
Cano, Jorge
Boer, Margriet den
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2012-05-31
Volume: 7
Issue: 5
Pages: e35671
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0035671
PMC: PMC3365071
OpenAlex: W2107915297
Cited by: 5,141
References: 51
Citations by year: 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
FWCI: 310.03
Type: journal article
Language: en
Open access: gold
doi.org
Licence: public-domain
creativecommons.org/publicdomain/zero/1.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, public-domain)
Europe PMC (PubMed Central) (publishedVersion, public-domain)
PubMed Central (publishedVersion, public-domain)
PubMed (publishedVersion)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
Funders: Sanofi
Universidad de Medellín
Pan American Health Organization
Agencia Española de Cooperación Internacional para el Desarrollo
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
Keywords: leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
MeSH terms: Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks